BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 31125127)

  • 1. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.
    Threapleton CJ; Janjua S; Fortescue R; Baker EH
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013024. PubMed ID: 31125127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
    Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital interventions for the management of chronic obstructive pulmonary disease.
    Janjua S; Banchoff E; Threapleton CJ; Prigmore S; Fletcher J; Disler RT
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013246. PubMed ID: 33871065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for exacerbations of asthma.
    Normansell R; Sayer B; Waterson S; Dennett EJ; Del Forno M; Dunleavy A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002741. PubMed ID: 29938789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent prophylactic antibiotics for bronchiectasis.
    Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
    Ni H; Aye SZ; Naing C
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide antibiotics for bronchiectasis.
    Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.
    Gendron LM; Nyberg A; Saey D; Maltais F; Lacasse Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012290. PubMed ID: 30306545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.